Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2020 4
2021 5
2022 6
2023 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.
Gonella LA, Moretti F, Capuano A, De Sarro C, Ferrara L, Geninatti E, Guarnieri G, Hysolakoj X, Lalli M, Leoni O, Mangano AMP, Marani Toro P, Mecchia V, Merlano MC, Palleria C, Potenza AM, Rossi P, Rossi M, Sanità F, Sapigni E, Scavone C, Sommaro C, Tuccori M, Zanoni G, Moretti U, VigiVax Working Group. Gonella LA, et al. Among authors: de sarro c. Vaccines (Basel). 2024 Sep 20;12(9):1076. doi: 10.3390/vaccines12091076. Vaccines (Basel). 2024. PMID: 39340106 Free PMC article.
The potential role of cannabinoids in epilepsy treatment.
De Caro C, Leo A, Citraro R, De Sarro C, Russo R, Calignano A, Russo E. De Caro C, et al. Among authors: de sarro c. Expert Rev Neurother. 2017 Nov;17(11):1069-1079. doi: 10.1080/14737175.2017.1373019. Epub 2017 Sep 4. Expert Rev Neurother. 2017. PMID: 28845714 Review.
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region.
Fabiano A, De Sarro C, Frajia D, Bosco F, Guarnieri L, Ruga S, Rodinò S, Sebkova L, Ciliberto E, Buoncompagni I, Costantino L, Leo A, Marcianò G, Rania V, Citraro R, Michael A, De Sarro G. Fabiano A, et al. Among authors: de sarro c. Pharmacol Rep. 2025 Oct;77(5):1415-1427. doi: 10.1007/s43440-025-00774-x. Epub 2025 Aug 19. Pharmacol Rep. 2025. PMID: 40828456 Free PMC article.
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes.
Cassano V, Tallarico M, Armentaro G, De Sarro C, Iannone M, Leo A, Citraro R, Russo E, De Sarro G, Hribal ML, Sciacqua A. Cassano V, et al. Among authors: de sarro c. Int J Mol Sci. 2022 Dec 18;23(24):16160. doi: 10.3390/ijms232416160. Int J Mol Sci. 2022. PMID: 36555798 Free PMC article.
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G, Sturkenboom M; ilmiovaccinoCOVID19 collaborating group. Ahmadizar F, et al. Drug Saf. 2023 Jun;46(6):575-585. doi: 10.1007/s40264-023-01304-5. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37103643 Free PMC article.
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study.
Tallarico M, Palleria C, Ruffolo L, Spagnuolo R, Naturale MD, De Francesco AE, De Sarro C, Romeo R, Citraro R, Doldo P, Abenavoli L, Gallelli L, Luzza F, Leo A, De Sarro G. Tallarico M, et al. Among authors: de sarro c. Pharmaceutics. 2022 Nov 13;14(11):2449. doi: 10.3390/pharmaceutics14112449. Pharmaceutics. 2022. PMID: 36432640 Free PMC article.
25 results